---
figid: PMC5831833__OMCL2018-8023821.001
figtitle: Schematic overview of the autophagy pathway and target points of its modulators
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC5831833
filename: OMCL2018-8023821.001.jpg
figlink: /pmc/articles/PMC5831833/figure/fig1/
number: F1
caption: 'Schematic overview of the autophagy pathway and target points of its modulators.
  Activation of AMPK and inhibition of mTORC, upon nutrient deprivation, lead to ULK
  complex activation. Subsequently, ULK complex phosphorylates Beclin1, causing VPS34
  activation and phagophore formation. Functional ULK complex consists of ULK1, ULK2,
  FIP200, and ATG13. VPS34, a regulatory subunit, VPS15, and Beclin1 associate with
  regulatory factor ATG14 forming functional PI3K-Beclin1 complex. Activation of AMPK
  inhibits the mTORC complex through the TSC/Rheb pathway. Multiple ATG proteins constitute
  two ubiquitin-like conjugation systems and mediate the generation of lipidated LC3
  proteins, which direct LC3 incorporation into the phagophore membrane. Finally,
  an elongated phagophore closes, forming autophagosome, which then fuses with lysosome,
  leading to cargo degradation and nutrient recycling. Current approaches of autophagy
  modulation are targeting various autophagy steps: activation of autophagy by mTOR
  complex blockage with sorafenib, everolimus, rapamycin, and its analogues; inhibition
  of autophagy through inhibition of ULK complex by ULK inhibitors; inhibition of
  PI3K complex with 3-MA or wortmannin; and activation of autophagy through autophagosome
  formation induction with 5-FU and autophagosome-lysosome fusion block with HCQ and
  CQ.'
papertitle: 'Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.'
reftext: Mija MarinkoviÄ‡, et al. Oxid Med Cell Longev. 2018;2018:8023821.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8907564
figid_alias: PMC5831833__F1
figtype: Figure
redirect_from: /figures/PMC5831833__F1
ndex: 27c153c3-df15-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5831833__OMCL2018-8023821.001.html
  '@type': Dataset
  description: 'Schematic overview of the autophagy pathway and target points of its
    modulators. Activation of AMPK and inhibition of mTORC, upon nutrient deprivation,
    lead to ULK complex activation. Subsequently, ULK complex phosphorylates Beclin1,
    causing VPS34 activation and phagophore formation. Functional ULK complex consists
    of ULK1, ULK2, FIP200, and ATG13. VPS34, a regulatory subunit, VPS15, and Beclin1
    associate with regulatory factor ATG14 forming functional PI3K-Beclin1 complex.
    Activation of AMPK inhibits the mTORC complex through the TSC/Rheb pathway. Multiple
    ATG proteins constitute two ubiquitin-like conjugation systems and mediate the
    generation of lipidated LC3 proteins, which direct LC3 incorporation into the
    phagophore membrane. Finally, an elongated phagophore closes, forming autophagosome,
    which then fuses with lysosome, leading to cargo degradation and nutrient recycling.
    Current approaches of autophagy modulation are targeting various autophagy steps:
    activation of autophagy by mTOR complex blockage with sorafenib, everolimus, rapamycin,
    and its analogues; inhibition of autophagy through inhibition of ULK complex by
    ULK inhibitors; inhibition of PI3K complex with 3-MA or wortmannin; and activation
    of autophagy through autophagosome formation induction with 5-FU and autophagosome-lysosome
    fusion block with HCQ and CQ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - PIK3C3
  - ATG14
  - ULK2
  - ATG13
  - RB1CC1
  - BECN1
  - ATG12
  - ATG4A
  - ATG4B
  - ATG4C
  - ATG4D
  - ATG5
  - ATG3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SLC25A4
  - SLC25A6
  - POLR3G
  - Slc12a3
  - Tsc22d1
  - Rheb
  - Akt1
  - Pik3r1
  - Rptor
  - Pik3c3
  - Atg14
  - Ulk2
  - Atg13
  - Rb1cc1
  - Pik3r4
  - Atg12
  - Atg5
  - Atg3
  - Pik3cg
  - Becn1
  - Prkaa2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tsc
  - Tsc1
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk
  - Pdk1
  - raptor
  - Atg17
  - Vps15
  - Atg6
  - Atg16
  - Atg4a
  - Atg4b
  - pe
  - Atg1
  - squ
  - SNF4Agamma
  - AMPKalpha
  - ant
  - sesB
  - Antp
  - ems
  - Sorafenib
  - Everolimus
  - Rapamycin
  - Wortmannin
  - PDK
  - 5-FU
---
